Form 4: Accenture CFO Angie Y. Park Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Accenture's Chief Financial Officer, Angie Y. Park, sold a total of 685 Class A ordinary shares on January 17, 2025, under a pre-arranged 10b5-1 trading plan.
Summary
- Accenture's Chief Financial Officer, Angie Y. Park, executed a sale of company stock on January 17, 2025.
- The sales were conducted under a pre-arranged Rule 10b5-1 trading plan.
- A total of 685 Class A ordinary shares were sold in multiple transactions.
- The shares were sold at weighted average prices of $354.0412, $354.852, and $355.9.
- The transactions resulted in a decrease in Ms. Park's direct holdings of Accenture Class A ordinary shares.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction under a pre-arranged trading plan, which is neither positive nor negative for the company's outlook.
Industry Context
Insider trading activity is a common occurrence in publicly traded companies, and these transactions are closely monitored by regulators and investors. The use of a 10b5-1 trading plan is a common practice to avoid accusations of insider trading.
Comparison to Industry Standards
- The use of 10b5-1 trading plans is a standard practice for executives at publicly traded companies like Accenture, similar to practices at companies such as IBM, Microsoft, and Oracle.
- The reported transactions are typical for executives managing their personal portfolios while adhering to insider trading regulations.
- The volume of shares sold is relatively small compared to the total outstanding shares of Accenture, which is common for routine executive sales.
Stakeholder Impact
- The share sales by the CFO may have a minor impact on shareholder sentiment, but the use of a 10b5-1 plan mitigates concerns about insider trading.
- The transactions do not directly impact employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 01/17/2025 | Date of the share sale transactions. |
| 01/21/2025 | Date the Form 4 was signed. |
Keywords
Accenture, ACN, insider trading, Form 4, 10b5-1, share sale, Angie Y. Park, CFO, equity securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.